News

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

By Jacob Gronholt-Pedersen COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, after it got U.S. approval ...

Millions of people ‘could be denied weight-loss jabs due to flawed NHS guidance’

Millions of people could be denied access to treatments such as weight-loss jabs because of flawed NHS guidance, a major think tank has warned.King’s Fund senior analyst Danielle Jefferies said Body ...